We thank Huixun Jia and Xiaodong Sun for their perspective on our study.1 The goals of this first-in-human trial were to identify safe doses of RGX-314 and an optimised protocol for advanced studies.

In patients with hemophilia, the knee joints represent approximately 45% of all occurrences of joint bleeding. In patients with hemophilia, the effectiveness of knee replacement surgery is impacted by ...

Sorry, there were no product categories that matched your search term. To improve our service and ensure this does not happen in the future, please take a moment to ...

Clearside Biomedical (CLSD) reported that Arctic Vision’s New Drug Application or NDA for arcatus for the treatment of uveitic macular edema has been formally accepted for review by the Center ...

Knocking out SbSLT1/2 reduces the amount of SL in root exudates, decreases Striga germination, and potentially mitigates yield loss in infested regions. In this illustration, on the left is shown the ...

Exudation, and Degeneration 2025 virtual meeting on February 8, 2025 and the BIO CEO & Investor Conference being held on February 10-11, 2025 at the New York Marriott Marquis in New York City.